Revelation Biosciences, Inc. Estimates – NASDAQ:REVB

REVB: Static price chart | Revelation Biosciences | US76135L8046

Revelation Biosciences To Carry Out 1-for-7 Reverse Stock Split On October 20th, 2026

Revelation Biosciences to implement 1-for-7 reverse stock split By Investing.com

Revelation Biosciences Announces 1-for-7 Reverse Stock Split Effective October 20

Revelation Biosciences Announces 1-for-7 Reverse Stock Split Effective October 20, 2026

Revelation Biosciences Announces 1-For-7 Reverse Stock Split, Effective Oct. 20

REVB Approaching a Critical Inflection Point

Revelation Biosciences, Inc. Announces Financial Results for the Three and Six Months Ended June 30, 2026

Independent Market Assessment Results Show $94 Billion Total Addressable Market for Gemini in Stage 2 and Stage 3 Acute Kidney Injury

Short Interest Alert: Most and least shorted sub-$2B healthcare stocks in July 2026

Revelation Biosciences Announces Adoption of Stockholder Rights Plan

REVB Forecast — Price Target — Prediction for 2027

Revelation Biosciences, Inc. Releases Corporate Update Letter to Stockholders

Revelation Biosciences, Inc. Announces Financial Results For the Three Months Ended March 31, 2026